Skip to content

Effect of Repetitive Transcranial Magnetic Stimulation on Chronic Pain and Central Sensitization in Patients with Knee Osteoarthritis: A Randomized Controlled Trial.

Effect of Repetitive Transcranial Magnetic Stimulation on Chronic Pain and Central Sensitization in Patients with Knee Osteoarthritis: A Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104340
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis.

Interventions

Control group (sham stimulation group):(1) Health education (2) aerobic exercise based on the FITT principle (3) Muscle strength training (4) sham stimulus
Experimental group (rTMS stimulation group):(1) Health education (2) aerobic exercise based on the FITT principle (3) Muscle strength training (4) In the experimental group, participants received a 15

Sponsors

Honghui Hospital, Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meets the KOA diagnostic criteria established by EULAR 2. Age > 40 years 3. Persistent or recurrent pain with a duration of more than 3 months 4. Brief Central Sensitization Inventory (CSI-9) score > 10 points 5. Patients sign the informed consent form and actively cooperate with the treatment

Exclusion criteria

Exclusion criteria: 1. Previous knee or hip arthroplasty 2. In the acute phase of a disease, such as unstable heart disease, systemic infection, and high fever, leading to difficulty and discomfort in testing 3. Pregnant women, or individuals with cognitive impairment 4. Presence of contraindications for TMS use, such as a history of neurological diseases and structural brain injury, presence of a cardiac pacemaker, increased intracranial pressure, metal or implanted devices within the skull, cochlear implants, history of epilepsy, and metabolic abnormalities 5. Use of drugs that may affect cortical electrical activity (anticonvulsants, antidepressants, or antipsychotics)

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale;Pressure Pain Thresholds;Movement-evoked Pain Index;Central Sensitization Inventory,CSI-9;Resting Motor Threshold;

Secondary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index;

Countries

China

Contacts

Public ContactXifang Liu

Honghui Hospital, Xi'an Jiaotong University

lxfyg2006@126.com+86 188 2179 2256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026